228 related articles for article (PubMed ID: 30131168)
21. Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement.
Hohenschurz-Schmidt DJ; Cherkin D; Rice ASC; Dworkin RH; Turk DC; McDermott MP; Bair MJ; DeBar LL; Edwards RR; Farrar JT; Kerns RD; Markman JD; Rowbotham MC; Sherman KJ; Wasan AD; Cowan P; Desjardins P; Ferguson M; Freeman R; Gewandter JS; Gilron I; Grol-Prokopczyk H; Hertz SH; Iyengar S; Kamp C; Karp BI; Kleykamp BA; Loeser JD; Mackey S; Malamut R; McNicol E; Patel KV; Sandbrink F; Schmader K; Simon L; Steiner DJ; Veasley C; Vollert J
Pain; 2023 Jul; 164(7):1457-1472. PubMed ID: 36943273
[TBL] [Abstract][Full Text] [Related]
22. Applying the pragmatic-explanatory continuum indicator summary to the implementation of a physical activity coaching trial in chronic obstructive pulmonary disease.
Nguyen HQ; Moy ML; Fan VS; Gould MK; Xiang A; Bailey A; Desai S; Coleman KJ
Nurs Outlook; 2018 Sep; 66(5):455-463. PubMed ID: 30144938
[TBL] [Abstract][Full Text] [Related]
23. Pragmatic dissemination and implementation research models, methods and measures and their relevance for nursing research.
Battaglia C; Glasgow RE
Nurs Outlook; 2018 Sep; 66(5):430-445. PubMed ID: 30093135
[TBL] [Abstract][Full Text] [Related]
24. Per-Protocol Analyses of Pragmatic Trials.
Hernán MA; Robins JM
N Engl J Med; 2017 Oct; 377(14):1391-1398. PubMed ID: 28976864
[No Abstract] [Full Text] [Related]
25. A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing.
Nicholls SG; Carroll K; Hey SP; Zwarenstein M; Zhang JZ; Nix HP; Brehaut JC; McKenzie JE; McDonald S; Weijer C; Fergusson DA; Taljaard M
J Clin Epidemiol; 2021 Sep; 137():45-57. PubMed ID: 33789151
[TBL] [Abstract][Full Text] [Related]
26. Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity.
Koehler M; Donnelly ET; Kalanovic D; Dagher R; Rothenberg ML
Ann Oncol; 2016 Jul; 27(7):1342-8. PubMed ID: 27029709
[No Abstract] [Full Text] [Related]
27. The shrinking scope of pragmatic trials: a methodological reflection on their domain of applicability.
Pawson R
J Clin Epidemiol; 2019 Mar; 107():71-76. PubMed ID: 30500404
[No Abstract] [Full Text] [Related]
28. Pros and cons of pragmatic clinical trials.
Lurie JD; Morgan TS
J Comp Eff Res; 2013 Jan; 2(1):53-8. PubMed ID: 24236521
[TBL] [Abstract][Full Text] [Related]
29. [Pragmatic trials are important to medical research].
Bjerre E; Brasso K; Midtgaard J
Ugeskr Laeger; 2015 Jul; 177(31):. PubMed ID: 26238009
[TBL] [Abstract][Full Text] [Related]
30. Trials without tribulations: Minimizing the burden of pragmatic research on healthcare systems.
Larson EB; Tachibana C; Thompson E; Coronado GD; DeBar L; Dember LM; Honda S; Huang SS; Jarvik JG; Nelson C; Septimus E; Simon G; Johnson KE
Healthc (Amst); 2016 Sep; 4(3):138-41. PubMed ID: 27637816
[TBL] [Abstract][Full Text] [Related]
31. Pragmatic guidance for embedding pragmatic clinical trials in health plans: Large simple trials aren't so simple.
Cocoros NM; Gurwitz JH; Cziraky MJ; Granger CB; Harkins T; Haynes K; Li X; Parlett L; Seeger JD; Singh S; McMahill-Walraven CN; Platt R
Clin Trials; 2023 Aug; 20(4):416-424. PubMed ID: 37322894
[TBL] [Abstract][Full Text] [Related]
32. Pragmatic clinical trials in the context of regulation of medicines.
Gedeborg R; Cline C; Zethelius B; Salmonson T
Ups J Med Sci; 2019 Jan; 124(1):37-41. PubMed ID: 30251577
[TBL] [Abstract][Full Text] [Related]
33. Pragmatic trials in primary care. Methodological challenges and solutions demonstrated by the DIAMOND-study.
Fransen GA; van Marrewijk CJ; Mujakovic S; Muris JW; Laheij RJ; Numans ME; de Wit NJ; Samsom M; Jansen JB; Knottnerus JA
BMC Med Res Methodol; 2007 Apr; 7():16. PubMed ID: 17451599
[TBL] [Abstract][Full Text] [Related]
34. Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.
Kalkman S; van Thiel GJ; Grobbee DE; Meinecke AK; Zuidgeest MG; van Delden JJ;
Trials; 2016 Aug; 17(1):419. PubMed ID: 27550379
[TBL] [Abstract][Full Text] [Related]
35. Quality standards for real-world research. Focus on observational database studies of comparative effectiveness.
Roche N; Reddel H; Martin R; Brusselle G; Papi A; Thomas M; Postma D; Thomas V; Rand C; Chisholm A; Price D;
Ann Am Thorac Soc; 2014 Feb; 11 Suppl 2():S99-104. PubMed ID: 24559028
[TBL] [Abstract][Full Text] [Related]
36. Methodological considerations when analysing and interpreting real-world data.
Stürmer T; Wang T; Golightly YM; Keil A; Lund JL; Jonsson Funk M
Rheumatology (Oxford); 2020 Jan; 59(1):14-25. PubMed ID: 31834408
[TBL] [Abstract][Full Text] [Related]
37. The cohort multiple randomized controlled trial design: a valid and efficient alternative to pragmatic trials?
van der Velden JM; Verkooijen HM; Young-Afat DA; Burbach JP; van Vulpen M; Relton C; van Gils CH; May AM; Groenwold RH
Int J Epidemiol; 2017 Feb; 46(1):96-102. PubMed ID: 27118559
[TBL] [Abstract][Full Text] [Related]
38. Pragmatic trials and implementation science: grounds for divorce?
Pawson R
BMC Med Res Methodol; 2019 Aug; 19(1):176. PubMed ID: 31420024
[TBL] [Abstract][Full Text] [Related]
39. Designing pragmatic trials-what can we learn from lessons learned?
Groenwold RHH; Dekkers OM
J Clin Epidemiol; 2017 Oct; 90():3-5. PubMed ID: 28629700
[TBL] [Abstract][Full Text] [Related]
40. Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real world.
Welsing PM; Oude Rengerink K; Collier S; Eckert L; van Smeden M; Ciaglia A; Nachbaur G; Trelle S; Taylor AJ; Egger M; Goetz I;
J Clin Epidemiol; 2017 Oct; 90():99-107. PubMed ID: 28502810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
